BioNTech expects vaccine trial results for babies by September

BioNTech Chief Executive said that in July, the first results could be available for five to 12 year olds, and in September for the younger children. BioNTech and Pfizer asked FDA this month to approve emergency use of their vaccine for adolescents aged 12 to 15.

Source:

Reuters Health